A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2016
At a glance
- Drugs Bavituximab (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 20 Apr 2016 Status changed from active, no longer recruiting to completed.
- 31 Mar 2015 Results published in the peer-reviewed journal Cancer Medicine, according to Peregrine Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History